Your browser doesn't support javascript.
loading
Vaccines in the Treatment of Substance Abuse.
Shorter, Daryl; Kosten, Thomas R.
Afiliação
  • Shorter D; Pharmacology and Neuroscience, Menninger Department of Psychiatry and Behavioral Science, Baylor College of Medicine, National VA Substance Use Disorders, Quality Enhancement Research Initiative (QUERI); Michael E. DeBakey Veterans Administration Medical Center, Houston, TX.
Focus (Am Psychiatr Publ) ; 2011(9): 25-30, 2011 Dec 01.
Article em En | MEDLINE | ID: mdl-23472050
Reconceptualizing drugs as toxins allowed an important shift in the approach to the treatment of substance abuse, because it ushered in consideration of immunological methods of pharmacotherapy. This paradigm shift represented a dramatic departure from previously considered approaches to pharmacotherapy for substance use disorders (SUDs), which had up until that time focused predominantly on either agonist and/or antagonist medications meant to block drug effects or to decrease reward, reinforcement, or craving. Use of immunological theory in SUD treatment also meant that 1) a potentially addicting medication would not be administered as part of therapy and 2) side effects could be limited, because the individual's immune system would be responsible for delivering treatment.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Focus (Am Psychiatr Publ) Ano de publicação: 2011 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Focus (Am Psychiatr Publ) Ano de publicação: 2011 Tipo de documento: Article País de publicação: Estados Unidos